Skip to main content
SpringerLink
Log in

Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system

  • Published:
Journal of Neurocytology

Abstract

In this mini-review are first presented data which highlight the capacity and characteristics for estrogen to act as a neuroprotectant of the nigrostriatal dopaminergic system. Estrogen administration significantly attenuates the degree of striatal dopamine depletion to neurotoxins (MPTP, 6-OHDA and methamphetamine) which target the nigrostriatal dopaminergic system. This neuroprotection appears maximal with the 17-beta isomer, but some neuroprotection may also be present with the 17-alpha isomer of estradiol. Treatment with the anti-estrogen, tamoxifen, abolished estrogen's neuroprotective effects upon MPTP or methamphetamine-induced neurotoxicity. Estrogen also preserves striatal dopamine concentrations in gonadectomized male mice treated with MPTP, but neither testosterone nor dihydrotestosterone offer any neuroprotection. A brief review indicating a variety of potential means by which estrogen can function as a neuroprotectant is indicated. Included within this survey are presented estrogen's action as an antioxidant along with its capacity to affect monoamine oxidase, dopamine receptors/release, membrane morphology/fluidity, thermoregulation, blood flow and nitric oxide. This discussion is followed by a more detailed description of estrogen's actions upon the dopamine transporter, which is hypothesized to serve as one of the major mechanism involved with nigrostriatal dopaminergic neuroprotection. Overall, estrogen appears to inhibit dopamine transporter function by decreasing the affinity of the transporter. Such an effect could prevent neurotoxic agents from entering dopamine nerve terminals, thereby decreasing nigrostriatal neurodegeneration. Finally, some implications regarding this neuroprotectant capacity of estrogen are considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • ALI, S. F. & FREYALDENHOVEN, T. (1999) MPTP-a model of parkinson's disease. In Chemicals and Neurodegenerative Disease (edited by BONDY, S. C.) pp. 160–188. Scottsdale, AZ: Prominent Press.

    Google Scholar 

  • ANDERSON, L. I., MC DERMOTT, J. L. & DLUZEN, D. E. (1999) Estrogen-tamoxifen interactions upon striatal dopaminergic neurotoxicity produced by MPTP. Neuroscience Abstracts 25, 2088.

    Google Scholar 

  • ARNAULD, E., DUFY, B., PESTRE, M. & VINCENT, J. D. (1981) Effects of estrogens on the responses of caudate neurons to microiontophoretically applied dopamine. Neuroscience Letters 21, 325–331.

    PubMed  Google Scholar 

  • ASTHANA, S., BAKER, L. D., CRAFT, S., RASKIND, M. A., AVERY, E., LOFGREEN, C. P., CHERRIER, M. & PLYMATE, S. R. (1999) Cognitive and neuroendocrine Estrogen and nigrostriatal neuroprotection 395 responses to estrogen in postmenopausal women with alzheimer's disease. Neuroscience Abstracts 25, 52.

    Google Scholar 

  • ATTALI, G., WEIZMAN, A., GIL-AD, I. & REHAVI, M. (1997) Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Research 756, 153–159.

    PubMed  Google Scholar 

  • AYRES, S., TANG, M. & SUBBIAH, M. T. (1996) Estradiol-17beta as an antioxidant: Some distinct features when compared with common fat-soluble antioxidants. Journal of Laboratory and Clinical Medicine 128, 367–375.

    PubMed  Google Scholar 

  • BAKER, L. D., CRAFT, S., LOFGREEN, C., AVERY, E., RASKIND, M. A., CHERRIER, M., VEITH, R. C., PLYMATE, S. R. & ASTHANA, S. (1999) Dose-response estrogen-induced cognitive enhancements for postmenopausal women with Alzheimer's disease. Society for Neuroscience Abstracts 25, 53.

    Google Scholar 

  • BARBER, P. V., ARNOLD, A. G. & EVANS, G. (1976) Recurrent hormone dependent chorea: Effects of oestrogens and progesterones. Clinical Endocrinology 5, 291–293.

    PubMed  Google Scholar 

  • BAZZETT, T. J. & BECKER, J. B. (1994) Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding. Brain Research 637, 163–172.

    PubMed  Google Scholar 

  • BECKER, J. B. (1990) Direct effect of 17 beta-estradiol on striatum: Sex differences in dopamine release. Synapse 5, 157–164.

    PubMed  Google Scholar 

  • BECKER, J. B. (1999) Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacology, Biochemistry and Behavior 64, 803–812.

    Google Scholar 

  • BECKER, J. B. & BEER, M. E. (1986) The influence of estrogen on nigrostriatal dopamine activity: Behavioral and neurochemical evidence for both pre-and post-synaptic components. Behavioral Brain Research 19, 27–33.

    Google Scholar 

  • BECKER, J. & RAMIREZ, V. D. (1981) Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro. Brain Research 204, 361–372.

    PubMed  Google Scholar 

  • BECKER, J. B. & RUDICK, C. N. (1999) Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: A microdialysis study. Pharmacology, Biochemistry and Behavior 64, 53–57.

    Google Scholar 

  • BEDARD, P. J., DI PAOLO, T., LANGELIER, P., POYET, P. & LABRIE, F. (1981) Behavioral and biochemical evidence of an effect of estradiol on striatal dopamine receptors. In Steroid Hormone Regulation of the Brain (edited by FUXE, K., GUSTAFSSON, J.-A. & WETTERBERG, L.) pp. 331–339. Oxford: Pergamon Press.

    Google Scholar 

  • BEDARD, P. J., LANGELIER, P. & VILLENEUVE, A. (1977) Oestrogens and extrapyramidal system. Lancet 2, 1367–1368.

    Google Scholar 

  • BEHL, C., SKUTELLA, T., LEZOUALC'H, F., POST, A., WIDMANN, M., NEWTON, C. J. & HOLSBOER, F. (1997) Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Molecular Pharmacology 51, 535–541.

    PubMed  Google Scholar 

  • BEHL, C., WIDMANN, M., TRAPP, T. & HOLSBOER, F. (1995) 17-B estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochemical and Biophysical Research Communications 216, 473–482.

    PubMed  Google Scholar 

  • BROOKS, W. J., JARVIS, M. F. & WAGNER, G. C. (1989) Influence of sex, age and strain on MPTP-induced neurotoxicity. Research Communications on Substance Abuse 10, 181–184.

    Google Scholar 

  • CARDINALI, D. P. & GOMEZ, E. (1977) Changes in hypothalamic noradrenaline, dopamine and serotonin uptake after oestradiol administration to rats. Journal of Endocrinology 73, 181–182.

    PubMed  Google Scholar 

  • CARDINALI, D. P., RITTA, M. N., VACAS, M. I., LOWENSTEIN, P. R., GEJMAN, P. V., GONZALEZ-SOLVEYRA, C. & PEREYRA, E. (1982) Molecular aspects of neuroendocrine integrative processes in the pineal gland. In The pineal gland and its endocrine role (edited by AXELROD, J., FRASCHINI, F. & VELO, G. P.) pp. 199–219. New York: Plenum Press.

    Google Scholar 

  • CASS, W. A., ZAHNISER, N. R., FLACH, K. A. & GERHARDT, G. A. (1993) Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: Role of metabolism and effects of locally applied uptake inhibitors. Journal of Neurochemistry 61, 2269–2278.

    PubMed  Google Scholar 

  • CHIBA, K., TREVOR, A. J. & CASTAGNOLI, N. (1985) Active uptake of MPP+, a toxic metabolite of MPTP, by brain synaptosomes. Biochemistry and Biophysical Research Communications 128, 1228–1233.

    Google Scholar 

  • CHAKRAVORTY, S. G. & HALBREICH, U. (1997) The influence of estrogen on monoamine oxidase activity. Psychopharmacological Bulletin 33, 229–233.

    Google Scholar 

  • CHEN, J. C. & RAMIREZ, V. D. (1988) Comparison of the effect of prolactin on the dopamine release from the rat dorsal and ventral striatum and from the mediobasal hypothalamus in vitro. European Journal of Pharmacology 149, 1–8.

    PubMed  Google Scholar 

  • CHEN, X. L., LI, R. & GUPTA, M. (1995) Estrogen may protect females from parkinson's disease. Society for Neuroscience Abstracts 21, 1252.

    Google Scholar 

  • CHEVILLARD, C., BARDEN, N. & SAAVEDRA, J. M. (1981) Estradiol treatment decreases typeA and increases type B monoamine oxidase in specific brain stem areas and cerebellum of ovariectomized rats. Brain Research 222, 177–181.

    PubMed  Google Scholar 

  • CHIODO, L. A., CAGGIULA, A. R. & SALLER, C. F. (1981) Estrogen potentiates the stereotypy induced by dopamine agonists in the rat. Life Sciences 28, 827–835.

    PubMed  Google Scholar 

  • CLARK, P. B. S. & REUBEN, M. (1995) Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: Possible action at the dopamine transporter. British Journal of Pharmacology 114, 315–322.

    PubMed  Google Scholar 

  • COSTA, M. M., REUS, V. I., WOLKOWITZ, O. M., MANFREDI, F. & LIEBERMAN, M. (1999) Estrogen replacement therapy and cognitive decline in memory impaired post-menopausal women. Biological Psychiatry 46, 182–188.

    PubMed  Google Scholar 

  • CROWLEY, W. R., O'DONOHUE, T. L. & JACOBOWITZ, D. M. (1978) Sex differences in catecholamine content in discrete brain nuclei of the rat: Effects of neonatal castration or testosterone treatment. Acta Endocrinologica 89, 20–28.

    PubMed  Google Scholar 

  • DEL ZOMPO, M., PICCARDI, M. P., RUIU, S., CORSINI, G. U. & VACCARI, A. (1992) Characterization of a putatively vesicular binding site for [3H]MPP+ in mouse striatal membranes. Brain Research 571, 354–357.

    PubMed  Google Scholar 

  • DICKO, A., MORISSETTE, M., AMEUR, S. B., PEZOLET, M. & DI PAOLO, T. (1999) Effect of estradiol and tamoxifen on brain membranes: Investigation by infrared and fluorescence spectroscopy. Brain Research Bulletin 49, 401–405.

    PubMed  Google Scholar 

  • DI PAOLO, T. (1994) Modulation of brain dopamine transmission by sex steroids. Reviews in Neuroscience 5, 27–42.

    Google Scholar 

  • DI PAOLO, T., DAIGLE, M. & LABRIE, F. (1984) Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors. Psychoneuroendocrinology 9, 399–404.

    PubMed  Google Scholar 

  • DI PAOLO, T., POYET, P. & LABRIE, F. (1982) Effect of prolactin and estradiol on rat striatal dopamine receptors. Life Sciences 31, 2921–2929.

    PubMed  Google Scholar 

  • DI PAOLO, T., ROULLIARD, C. & BEDARD, P. (1985) 17B-estradiol at a physiological dose acutely increases dopamine turnover in rat brain. European Journal of Pharmacology 117, 197–203.

    PubMed  Google Scholar 

  • DISSHON, K. A., BOJA, J. W. & DLUZEN, D. E. (1998) Inhibition of striatal dopamine transporter activity by 17B-estradiol. European Journal of Pharmacology 345, 207–211.

    PubMed  Google Scholar 

  • DISSHON, K. A. & DLUZEN, D. E. (1997) Estrogen as a modulator of MPTP-induced neurotoxicity: Effects upon corpus striatal dopamine release. Brain Research 764, 9–16.

    PubMed  Google Scholar 

  • DISSHON, K. A. & DLUZEN, D. E. (1999a) Comparison of 17a-and 17B-estradiol upon striatal dopaminergic neurotoxicity produced by MPTP. Society for Neuroscience Abstracts 25, 2088.

    Google Scholar 

  • DISSHON, K. A. & DLUZEN, D. E. (1999b) Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: Influence of estrogen. Brain Research 842, 399–407.

    PubMed  Google Scholar 

  • DISSHON, K. A. & DLUZEN, D. E. (2000) Estrogen reduces MPP+ acute striatal dopamine responses in vivo to the Neurotoxin in female, but not male rats. Brain Research 868, 95–104.

    PubMed  Google Scholar 

  • DLUZEN, D. E. (1996) The effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system in male C57/Bl mice. Brain Research 715, 113–118.

    PubMed  Google Scholar 

  • DLUZEN, D. E. (1997) Estrogen decreases corpus striatal neurotoxicity in response to 6-OHDA. Brain Research 767: 340–344.

    PubMed  Google Scholar 

  • DLUZEN, D. E., DISSHON, K. A. & MC DERMOTT, J. L. (1998) Estrogen as a modulator of striatal dopaminergic neurotoxicity. In Recent Advances in Neurodegenerative Disorders (edited by MARWAH, J. & TIETELBAUM, H.) pp. 149–192. Scottsdale, AZ: Prominent Press.

    Google Scholar 

  • DLUZEN, D. E., LIU, B., CHEN, C.-Y. & DI CARLO, S. E. (1995) Daily spontaneous running alters behavioral and neurochemical indexes of nigrostriatal function. Journal of Applied Physiology 78, 1219–1224.

    PubMed  Google Scholar 

  • DLUZEN, D. E. & MC DERMOTT, J. L. (2000) Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system. Annals of the New York Academy of Sciences 914, 112–126.

    PubMed  Google Scholar 

  • DLUZEN, D. E., MC DERMOTT, J. L. & LIU, B. (1996a) Estrogen alters MPTP-induced neurotoxicity in female mice: Effects of striatal dopamine concentrations and release. Journal of Neurochemistry 66, 658–666.

    PubMed  Google Scholar 

  • DLUZEN, D. E., MC DERMOTT, J. L. & LIU, B. (1996b) Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/Bl mice. Neurotoxicology and Teratology 18, 603–606.

    PubMed  Google Scholar 

  • ENERSBY, C. A. & WILSON, C. A. (1974) The effect of ovarian steroids on the accumulation of 3H-labelled monoamines by hypothalamic tissue in vitro. Brain Research 73, 321–331.

    PubMed  Google Scholar 

  • EUVRARD, C., OBERLANDER, C. & BOISSIER, J. R. (1980) Antidopaminergic effect of estrogen at the striatal level. Journal of Pharmacology and Experimental Therapeutics 214, 179–185.

    PubMed  Google Scholar 

  • FALARDEAU, P. & DI PAOLO, T. (1987) Regional effect of estradiol on rat caudate putamen dopamine receptors: Lateral-medial differences. Neuroscience Letters 74, 43–48.

    PubMed  Google Scholar 

  • FERNANDEZ-RUIZ, J. J., AMOR, J. C. & RAMOS, J. A. (1989) Time-dependent effects of estradiol and progesterone on the number of striatal dopaminergic D2-receptors. Brain Research 476, 388–395.

    PubMed  Google Scholar 

  • FERNANDEZ-RUIZ, J. J., DE MIGUEL, R., HERNANDEZ, M. L., CEBEIRA, M. & RAMOS, J. A. (1992) Comparisons between brain dopaminergic neurons of juvenile and aged rats: Sex-related differences. Mechanisms of Ageing and Development 63, 45–55.

    PubMed  Google Scholar 

  • FIGLEWICZ, D. P. (1999) Endocrine regulation of neurotransmitter transporters. Epilepsy Research 37, 203–210.

    PubMed  Google Scholar 

  • FREYALDENHOVEN, T. E., CADET, J. L. & ALI, S. F. (1996) The dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender dependent. Brain Research 735, 232–238.

    PubMed  Google Scholar 

  • GAINETDINOV, R. R., FUMAGALLI, F., JONES, S. R. & CARON, M. G. (1997) Dopamine transporter is required for in vivo MPTP neurotoxicity: Evidence from mice lacking the transporter. Journal of Neurochemistry 69, 1322–1325.

    PubMed  Google Scholar 

  • GAMBOA, E. T., ISAACS, G. & HARTER, D. H. Chorea associated with oral contraceptive therapy. Archives of Neurology 25, 112–114.

  • GAO, X. & DLUZEN, D. E. (2000) Estrogen treatment protects, but does nor restore, nigrostriatal function in methamphetamine treated mice. The FASEB Journal 14, AI474.

    Google Scholar 

  • GIBBS, R. B. (1999) Treatment with estrogen and progesterone affects relative levels of brain derived neurotrophic factor mRNA and protein in different regions of the adult rat brain. Brain Research 844, 20–27.

    PubMed  Google Scholar 

  • GLAZER, W. M., NAFTOLIN, F., MOORE, D. C., BOWERS, M. B. & MAC LUSKY, N. J. (1983) The relationship of circulating estradiol to tardive dykinesia in men and postmenopausal women. Psychoneuroendocrinology 8, 429–434.

    PubMed  Google Scholar 

  • GOLDMAN, H., SKELLEY, E. B., SANDMAN, C. A., CASTIN, A. J. & MURPHY, S. (1976) Hormones and regional blood flow. Pharmacology, Biochemistry and Behavior 5 (Suppl 1), 165–169.

    Google Scholar 

  • GOODMAN, Y., BRUCE, A. J., CHENG, B. & MATTSON, M. P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid B-peptide toxicity in hippocampal neurons. Journal of Neurochemistry 66, 1836–1844.

    PubMed  Google Scholar 

  • GORDON, J. H. & PERRY, K. O. (1983) Pre-and postsynaptic neurochemical alteration following estrogen-induced striatal dopamine hypo-and hypersensitivity. Brain Research Bulletin 10, 425–428.

    PubMed  Google Scholar 

  • GRAHAM, D. G. (1984) Catecholamine toxicity: A proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicity 5, 83–95.

    Google Scholar 

  • GRANDBOIS, M., TANGUAY, B. & DI PAOLO, T. (1999) Estradiol and dehydroepiandrosterone but not dihydrotestosterone protect against MPTP-induced dopamine depletion in mice. Society for Neuroscience Abstracts 25, 1595.

    Google Scholar 

  • GREEN, P. S., BISHOP, J. & SIMPKINS, J. W. (1997) 17a-estradiol exerts neuroprotective effects on SK-N-SH cells. Journal of Neuroscience 17, 511–515.

    PubMed  Google Scholar 

  • GREEN, P. S., GRIDLEY, K. E. & SIMPKINS, J. W. (1996) Estradiol protects against B-amyloid (25–35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neuroscience Letters 218, 165–168.

    PubMed  Google Scholar 

  • HASHIMOTO, M., HOSSAIN, S. & MASUMURA, S. (1999) Effect of aging on plasma membrane fluidity of rat aortic endothelial cells. Experimental Gerontology 34, 687–698.

    PubMed  Google Scholar 

  • HEIKKILA, R. E., YOUNGSTER, S. K., MANZINO, L., CABBAT, F. S. & DUVOISIN, R. C. (1985). Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropryridine and related compounds on the uptake of [3H]3,4dihydroxyphenylethylamine and [3H]5-hydroxytryptamine on neostriatal synaptosomal preparations. Journal of Neurochemistry 44, 310–313.

    PubMed  Google Scholar 

  • HRUSKA, R. E., LUDMER, L. M. & SILBERGELD, E. K. (1980) Characterization of the striatal dopamine receptor supersensitivity produced by estrogen treatment of male rats. Neuropharmacology 19, 923–926.

    PubMed  Google Scholar 

  • HUANG, A., SUN, D., KALEY, G. & KOLLER, A. (1997) Estrogen maintains nitric oxide synthesis in arterioles of female hypertensive rats. Hypertension 29, 1351–1356.

    PubMed  Google Scholar 

  • ISLES, C. G., HOLE, D. J., HAWTHORNE, V. M. & LEVER, A. F. (1992) Relation between coronary risk and coronary mortality in women of the Renfew and Paisley survey: Comparison with men. Lancet 339, 702–706.

    PubMed  Google Scholar 

  • JABER, M., JONES, S., GIROS, B. & CARON, M. G. (1997) The dopamine transporter: A crucial component regulating dopamine transmission. Movement Disorders 12, 629–633.

    PubMed  Google Scholar 

  • JAVITCH, J. A., D'AMATO, R. J., STRITTMATTER, S. M. & SYNDER, S. H. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective neurotoxicity. Proceedings of the National Academy of Sciences of the USA 82, 2173–2177.

    PubMed  Google Scholar 

  • JIN, B. K., SHIN, D. Y., JEONG, MI, Y., GWAG MI, R., BAIK, H. W., YOON, K. S., CHO, Y. H., JOO, W. S., KIM, Y. S. & BAIK, H. H. (1998) Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats. Neuroscience Letters 245, 61–64.

    PubMed  Google Scholar 

  • JONES, S. R., GAINETDINOV, R. R., JABER, M. M., GIROS, B., WIGHTMAN, R. M. & CARON, M. G. (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proceedings of the National Academy of Sciences of the USA 95, 4029–4034.

    PubMed  Google Scholar 

  • JORDAN, V. G. & MORROW, M. (1999) Tamoxifen, raloxifene, and the prevention of breast cancer. Endocrine Reviews 20, 253–278.

    PubMed  Google Scholar 

  • KLETZKY, O. A. & BORENSTEIN, R. (1987) Vasomotor instability of the menopause. In Menopause physiology and pharmacology (edited by MISHELL JR., D. R.) pp 53–65, Chicago: Year Book Medical Publishers Inc.

    Google Scholar 

  • KOLLER, W. C., BARR, A. & BIARY, N. (1982) Estrogen treatment of dyskinetic disorders. Neurology 32, 547–549.

    PubMed  Google Scholar 

  • LAMMERS, C.-H., D'SOUZA, U., QIN, Z.-H., LEE, S.-H., YAJIMA, S. & MOURADIAN, M. M. (1999) Regulation of striatal dopamine receptors by estrogen. Synapse 34, 222–227.

    PubMed  Google Scholar 

  • LEE, S.-H. & MOURADIAN, M. M. (1999) Up-regulation of D1A dopamine receptor gene transcription by estrogen. Molecular and Cellular Endocrinology 156, 151–157.

    PubMed  Google Scholar 

  • LEIPHEIMER, R. E., ARVIN, M. A., FEDORKOVA, L., DISSHON, K. A. & DLUZEN, D. E. (1998) Estrogen modulation of MPP+-stimulated dopamine secretion in the corpus striatum of rats using in vivo and in vitro techniques. Society for Neuroscience Abstracts 24, 1723.

    Google Scholar 

  • LEVESQUE, D. & DI PAOLO, T. (1988) Rapid conversion of high into low striatal D2-dopamine receptor agonist binding sites after an acute physiological dose of 17B-estradiol. Neuroscience Letters 88, 113–118.

    PubMed  Google Scholar 

  • LEVESQUE, D. & DI PAOLO, T. (1989) Chronic estradiol treatment increases ovariectomized rat striatal D-1 dopamine receptors. Life Sciences 45, 1813–1820.

    PubMed  Google Scholar 

  • MAGYAR, K., SZENDE, B., LENGYEL, J., TARCZALI, J. & SZATMARY, I. (1998) The neuroprotective and neurorescue effects of (?)-deprenyl. Journal of Neural Transmission Suppl 52, 109–123.

    Google Scholar 

  • MARDER, K., TANG, M.-X., ALFARO, B., MEJIA, H., COTE, L., JACOBS, D., STERN, Y., SANO, M. & MAYEUX, M. (1998) Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology 50, 1141–1143.

    PubMed  Google Scholar 

  • MARSHALL, J. F., O'DELL, S. J. & WEIHMULLER, F. B. (1993) Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. Journal of Neural Transmission 91, 241–254.

    PubMed  Google Scholar 

  • MC DERMOTT, J. L., KREUTZBERG, J. D., LIU, B. & DLUZEN, D. E. (1994a) Effects of estrogen treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice. Hormones and Behavior 28, 16–28.

    PubMed  Google Scholar 

  • MC DERMOTT, J. L., LIU, B. & DLUZEN, D. E. (1994b) Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Experimental Neurology 125, 306–311.

    PubMed  Google Scholar 

  • MC MILLAN, P. J., SINGER, C. A. & DORSA, D. M. (1996) The effect of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female sprague dawley rat. Journal of Neuroscience 16, 1860–1865.

    PubMed  Google Scholar 

  • MICHEL, P. P. & HEFTI, F. (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. Journal of Neuroscience Research 26, 428–435.

    PubMed  Google Scholar 

  • MICHEL, M. C., ROTHER, A., HIEMKE, C. & GHRAF, R. (1987) Inhibition of synaptosomal high-affinity uptake of dopamine and serotonin by estrogen agonists and antagonists. Biochemical Pharmacology 36, 3175–3180.

    PubMed  Google Scholar 

  • MILLER, D. B. (1998) Endocrine disruption: Estrogen, androgen, and the nervous system. In Neurotoxicity (edited by TILSON, H. A. & HARRY, G. J.) pp. 201–218, Taylor & Francis.

  • MILLER, D. B., ALI, S. F., O'CALLAGHAN, J. P. & LAWS, S. C. (1998) The impact of gender and estrogen on striatal dopamine neurotoxicity. Annals of the New York Academy of Sciences 844, 153–165.

    PubMed  Google Scholar 

  • MIRANDA, R. C. & SOHRABJI, F. (1996) Gonadal steroid receptors: Possible roles in the etiology and therapy of cognitive and neurological disorders. Annals of Reproductive Medicine and Chemistry 31, 11–20.

    Google Scholar 

  • MIURA, T., MURAOKA, S. & OGISO, T. (1996) Inhibition of lipid peroxidation by estradiol and 2-hydroxyestradiol. Steroids 61, 379–383.

    PubMed  Google Scholar 

  • MOOK-JUNG, I., JOO, I., SOHN, S., KWON, H. J., HUH, K. & JUNG, M. W. (1997) Estrogen blocks neurotoxic effects of B-amyloid (1–42) and induces neurite extension on B103 cells. Neuroscience Letters 235, 101–104.

    PubMed  Google Scholar 

  • MOORADIAN, A. D. (1993) Antioxidant properties of steroids. Journal of Steroid Biochemistry 45, 509–511.

    Google Scholar 

  • MORISSETTE, M., BIRON, D. & DI PAOLO, T. (1990) Effect of estradiol and progesterone on rat striatal uptake sites. Brain Research Bulletin 25, 419–422.

    PubMed  Google Scholar 

  • MORISSETTE, M., GARCIA-SEGURA, L.-M., BELANGER, A. & DI PAOLO, T. (1992) Changes of rat striatal neuronal membrane morphology and steroid content during the estrous cycle. Neuroscience 49, 893–902.

    PubMed  Google Scholar 

  • MOY, L. Y., ALBERS, D. S. & SONSALLA, P. K. (1998) Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice. Brain Research 790, 264–269.

    PubMed  Google Scholar 

  • NABULSI, A. A., FOLSON, A. R., WHITE, A., PATSCH, W., HEISS, G., WU, K. K. & SZKLO, M. (1993) Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. New England Journal of Medicine 328, 1069–1075.

    PubMed  Google Scholar 

  • NAKANO, M., SUGIOKA, K., NAITO, I., TAKEKOSHI, S. & NIKI, E. (1987) Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol. Biochemical and Biophysical Research Communications 142, 919–924.

    PubMed  Google Scholar 

  • O'DELL, S. J., WEIHMULLER, F. B. & MARSHALL, J. (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Research 564, 256–260.

    PubMed  Google Scholar 

  • OHKURA, T., TESHIMA, Y., ISSE, K., MATSUDA, H., INOUE, T., SAKAI, Y., IWASKI, N. & YAOI, Y. (1995) Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause 2, 13–18.

    Google Scholar 

  • PASQUALINI, C., OLIVIER, V., GUIBERT, B., FRAIN, O. & LEVIEL, V. (1995) Acute stimulatory effect of estradiol on striatal dopamine synthesis. Journal of Neurochemistry 65, 1651–1657.

    PubMed  Google Scholar 

  • RIEDERER, P., KONRADI, C., SCHAY, V., KIENZL, E., BIRKMAYER, G., DANIELCZYK, W., SOFIL, E. & YOUDIM, M. B. H. (1986) Localization of MAO-A and MAO-B in human brain: A step in understanding the therapeutic actions of L-deprenyl. Advances in Neurology 45, 111–118.

    Google Scholar 

  • RUIZ-LARREA, M. B., LEAL, A. M., LIZA, M., LACORT, M. & DE GROOT, H. (1994) Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59, 383–388.

    PubMed  Google Scholar 

  • RICAURTE, G. A., LANGSTON, J. W., DELANEY, L. E., IRWIN, I. & BROOKS, J. D. (1985) Dopamine uptake blockers protect against dopamine depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum. Neuroscience Letters 59, 259–264.

    PubMed  Google Scholar 

  • SANGHERA, M., MANAYE, K., MC MAHON, A., SONSALLA, P. K. & GERMAN, D. SC. (1997) Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP. NeuroReport 8, 3327–3331.

    PubMed  Google Scholar 

  • SANTIAGO, M., MACHARO, A. & CANO, J. (1994) Effect of L-arginine/nitric oxide pathway on MPP+-induced cell injury in the striatum of rats. British Journal of Pharmacology 111, 837–842.

    PubMed  Google Scholar 

  • SATOH, N., YONEZAWA, A., TADANO, T., KISARA, K., ARAI, Y. & KINEMUCHI, H. (1987) Acute effects of a parkinsonism-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mouse body temperature. Life Sciences 41, 1415–1424.

    PubMed  Google Scholar 

  • SAUNDERS-PULLMAN, R., GORDON-ELLIOT, J., PARIDES, M., FAHN, S., SAUNDERS, H. R. & BRESSMAN, S. (1999) The effect of estrogen replacement on early parkinson's disease. Neurology 52, 1417–1421.

    PubMed  Google Scholar 

  • SAUTTER, J., MEYER, M., SPENCER, C., SEILER, R. W. & WIDMER, H. R. (1998) Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons. NeuroReport 9, 1093–1096.

    PubMed  Google Scholar 

  • SCHWARTING, R. K. W. & HUSTON, J. P. (1996) Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Progress in Neurobiology 49, 215–266.

    PubMed  Google Scholar 

  • SINGER, C. A., PANG, P. A., DOBIE, D. J. & DORSA, D. M. (1996a) Estrogen increases GAP-43 (Neuromodulin) mRNAin preoptic area of aged rats. Neurobiology of Aging 17, 661–663.

    PubMed  Google Scholar 

  • SINGER, C. A., ROGERS, K. L., STRICKLAND, T. M. & DORSA, D. M. (1996b) Estrogen protects primary cortical neurons from glutamate toxicity. Neuroscience Letters 212, 13–16.

    PubMed  Google Scholar 

  • SINGH, M., MEYER, E. M. & SIMPKINS, J. W. (1995) The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female sprague dawley rats. Endocrinology 136, 2320–2324.

    PubMed  Google Scholar 

  • SPINA, M. B. & COHEN, G. (1989) Dopamine turnover and glutathione oxidation: Implications for parkinson's disease. Proceedings of the National Academy of Sciences of the USA 86, 1714–1718.

    Google Scholar 

  • STEPHENSON, J. (1999) Experts debate drugs for healthy women with breast cancer risk. Journal of the American Medical Association 282, 117–118.

    PubMed  Google Scholar 

  • THOMPSON, T. L. (1999) Attenuation of dopamine uptake in vivo following priming with estradiol benzoate. Brain Research 834, 164–167.

    PubMed  Google Scholar 

  • THOMPSON, T. L. & MOSS, R. L. (1994) Estrogen regulation of dopamine release in the nucleus accumbens: Estrogen and nigrostriatal neuroprotection 399 Genomic-and nongenomic-mediated effects. Journal of Neurochemistry 62, 1750–1756.

    PubMed  Google Scholar 

  • TRANQUILLI, A. L., MAZZANTI, L., CUGINI, A. M., CESTER, N., GARZETTI, G. G. & ROMANINI, C. (1995) Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants. Gynecological Endocrinology 9, 137–141.

    PubMed  Google Scholar 

  • TSAI, M. J. & LEE, E. H. Y. (1998) Nitric oxide donors protect cultured rat astrocytes from 1-methyl-4-phenylpyridinium-induce toxicity. Free Radical Biology and Medicine 24, 705–713.

    PubMed  Google Scholar 

  • VACCARI, A. & BIASSONI, R. (1982) Gonadal influence on the inhibition of monoamine oxidase type B activity. Journal of Neuroscience Research 8, 13–19.

    PubMed  Google Scholar 

  • VACCARI, A., DEL ZOMPO, M., MELIS, F., GESSA, G. L. & ROSSETTI, Z. L. (1991) Interactions of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine. British Journal of Pharmacology 104, 573–574.

    PubMed  Google Scholar 

  • VAN HARTESVELDT, C. & JOYCE, J. N. (1986) Effects of estrogen on the basal ganglia. Neuroscience & Biobehavioral Reviews 10, 1–14.

    Google Scholar 

  • VAN HORNE, C., HOFFER, B. J., STROMBERT, I. & GERHARDT, G. A. (1992) Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. Journal of Pharmacology and Experimental Therapeutics 263, 1285–1292.

    PubMed  Google Scholar 

  • WAGNER, G. C., TEKIRIAN, T. L. & CHEO, C. T. (1993) Sexual differences in sensitivity to methamphetamine toxicity. Journal of Neural Transmission 93, 67–70.

    PubMed  Google Scholar 

  • WEAVER, JR. C. E., PARK-CHUNG, M., GIBBS, T. T. & FARB, D. H. (1997) 17B-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Research 761, 338–341.

    PubMed  Google Scholar 

  • WEIHMULLER, F. B., O'DELL, S. J. & MARSHALL, J. F. (1992) MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse 11, 155–163.

    PubMed  Google Scholar 

  • WENGER, N. K., SPEROFF, L. & PACKARD, B. (1993) Cardiovascular health and disease in women. New England Journal of Medicine 329, 247–256.

    PubMed  Google Scholar 

  • WIRZ-JUSTICE, A., HACKMANN, E. & LICHTSTEINER, M. (1974) The effect of estradiol dipropionate and progesterone on monoamine uptake in rat brain. Journal of Neurochemistry 22, 187–189.

    PubMed  Google Scholar 

  • YOUNGSTER, S. K., NICKLAS, W. J. & HEIKKILA, R. E. (1989) Structure-activity study of the mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs. Journal of Pharmacology and Experimental Therapeutics 249, 829–835.

    PubMed  Google Scholar 

  • YU, Y.-L. & WAGNER, G. C. (1994) Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity. Journal of Neural Transmission 8, 215–221.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anatomy, Northeastern Ohio Universities College of Medicine, (NEOUCOM), Rootstown, Ohio, USA

    Dean E. Dluzen

Authors
  1. Dean E. Dluzen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dluzen, D.E. Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system. J Neurocytol 29, 387–399 (2000). https://doi.org/10.1023/A:1007117424491

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007117424491

Keywords

Search

Navigation